# Chemotherapy in Treating Patients With Chronic Lymphocytic Leukemia

> **NCT00006097** · PHASE1,PHASE2 · COMPLETED · sponsor: **Boston Medical Center**

## Conditions studied

- Leukemia

## Interventions

- **DRUG:** CC-1088

## Key facts

- **NCT ID:** NCT00006097
- **Lead sponsor:** Boston Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1999-08
- **Primary completion:** 2005-07
- **Final completion:** 2005-07
- **Target enrollment:** — (—)
- **Last updated:** 2010-09-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00006097

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00006097, "Chemotherapy in Treating Patients With Chronic Lymphocytic Leukemia". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00006097. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*